Sartorius Aktiengesellschaft (SRT) - Total Liabilities

Latest as of March 2026: €5.98 Billion EUR ≈ $6.99 Billion USD

Based on the latest financial reports, Sartorius Aktiengesellschaft (SRT) has total liabilities worth €5.98 Billion EUR (≈ $6.99 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SRT long-term investment intensity to see how much of total assets are deployed in long-term investments.

Sartorius Aktiengesellschaft - Total Liabilities Trend (2013–2025)

This chart illustrates how Sartorius Aktiengesellschaft's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SRT total asset value.

Sartorius Aktiengesellschaft Competitors by Total Liabilities

The table below lists competitors of Sartorius Aktiengesellschaft ranked by their total liabilities.

Company Country Total Liabilities
Lottomatica Group SpA
NYSE:LOTMY
USA $3.13 Billion
JD LOGISTICS DL-000025
F:822
Germany €61.81 Billion
Nkt A/S
NYSE:NRKBY
USA $3.38 Billion
Zhejiang Huafon Spandex Co Ltd
SHE:002064
China CN¥9.46 Billion
GS Holdings
KO:078930
Korea ₩17.00 Trillion
Noble Corporation plc
NYSE:NE
USA $2.89 Billion
UNO Minda Limited
NSE:UNOMINDA
India Rs64.45 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Sartorius Aktiengesellschaft's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Sartorius Aktiengesellschaft net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.91 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 2.19 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.61 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sartorius Aktiengesellschaft's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sartorius Aktiengesellschaft (2013–2025)

The table below shows the annual total liabilities of Sartorius Aktiengesellschaft from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 €5.85 Billion
≈ $6.84 Billion
-5.73%
2024-12-31 €6.21 Billion
≈ $7.25 Billion
-11.20%
2023-12-31 €6.99 Billion
≈ $8.17 Billion
+61.79%
2022-12-31 €4.32 Billion
≈ $5.05 Billion
+8.57%
2021-12-31 €3.98 Billion
≈ $4.65 Billion
+20.72%
2020-12-31 €3.30 Billion
≈ $3.85 Billion
+86.89%
2019-12-31 €1.76 Billion
≈ $2.06 Billion
+13.49%
2018-12-31 €1.55 Billion
≈ $1.82 Billion
+4.18%
2017-12-31 €1.49 Billion
≈ $1.74 Billion
+46.74%
2016-12-31 €1.02 Billion
≈ $1.19 Billion
+28.23%
2015-12-31 €792.48 Million
≈ $926.50 Million
+2.21%
2014-12-31 €775.37 Million
≈ $906.49 Million
+6.06%
2013-12-31 €731.07 Million
≈ $854.70 Million
--

About Sartorius Aktiengesellschaft

F:SRT Germany Medical Instruments & Supplies
Market Cap
$7.26 Billion
€6.21 Billion EUR
Market Cap Rank
#2809 Global
#559 in Germany
Share Price
€181.40
Change (1 day)
-1.31%
52-Week Range
€157.20 - €205.00
All Time High
€829.87
About

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell cult… Read more